These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32594997)

  • 1. Novel therapies in the management of oral cancer: An update.
    Nandini DB; Rao RS; Hosmani J; Khan S; Patil S; Awan KH
    Dis Mon; 2020 Dec; 66(12):101036. PubMed ID: 32594997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental Management of Patients Who Have Undergone Oral Cancer Therapy.
    Villa A; Akintoye SO
    Dent Clin North Am; 2018 Jan; 62(1):131-142. PubMed ID: 29126490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the oral sequelae of cancer therapy.
    Jones DL; Rankin KV
    Tex Dent J; 2012 May; 129(5):461-8. PubMed ID: 22779202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.
    Oliver RJ; Clarkson JE; Conway DI; Glenny A; Macluskey M; Pavitt S; Sloan P; ; Worthington HV
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006205. PubMed ID: 17943894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of oral cancer: an overview for dental professionals.
    Deng H; Sambrook PJ; Logan RM
    Aust Dent J; 2011 Sep; 56(3):244-52, 341. PubMed ID: 21884138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and Psychological Impairments Associated with Mucositis after Oral Cancer Treatment and Their Impact on Quality of Life.
    Jehn P; Stier R; Tavassol F; Dittmann J; Zimmerer R; Gellrich NC; Krüskemper G; Spalthoff S
    Oncol Res Treat; 2019; 42(6):342-349. PubMed ID: 30970370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach.
    Carvalho AL; Magrin J; Kowalski LP
    Oral Dis; 2003 May; 9(3):112-8. PubMed ID: 12945592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and xerostomia after postoperative radiotherapy for oral and oropharyngeal carcinoma.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Head Neck; 2014 Oct; 36(10):1467-73. PubMed ID: 23996878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dentist's role within the multi-disciplinary team maintaining quality of life for oral cancer patients in light of recent advances in radiotherapy.
    Brody S; Omer O; McLoughlin J; Stassen L
    J Ir Dent Assoc; 2013; 59(3):137-46. PubMed ID: 23858630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.
    Vigarios E; Epstein JB; Sibaud V
    Support Care Cancer; 2017 May; 25(5):1713-1739. PubMed ID: 28224235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RADIOTHERMOMETRIC PERSONALISATION OF CHEMO- AND RADIOTHERAPY FOR PATIENTS WITH ADVANCED (III, IVA AND IVB) STAGES MALIGNANT LESIONS OF ORAL CAVITY, THROAT AND EPIGLOTTIS.
    Bazyka D; Vorobyov M; Kechyn I; Vorobyov O; Shmykova O
    Probl Radiac Med Radiobiol; 2019 Dec; 24():296-311. PubMed ID: 31841475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locally Advanced Oral Cavity Cancers: What Is The Optimal Care?
    Alzahrani R; Obaid A; Al-Hakami H; Alshehri A; Al-Assaf H; Adas R; Alduhaibi E; Alsafadi N; Alghamdi S; Alghamdi M
    Cancer Control; 2020; 27(1):1073274820920727. PubMed ID: 32339002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental considerations in the management of head and neck cancer patients.
    Miller EH; Quinn AI
    Otolaryngol Clin North Am; 2006 Apr; 39(2):319-29. PubMed ID: 16580914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
    Doweck I; Robbins KT; Samant S; Vieira F
    World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing Intraoral Lesions in Oral Cancer Patients in a General Dental Practice: An Overview.
    Kim RH; Yang P; Sung EC
    J Calif Dent Assoc; 2016 Feb; 44(2):85-92. PubMed ID: 26930751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental Treatment Planning for the Patient with Oral Cancer.
    Levi LE; Lalla RV
    Dent Clin North Am; 2018 Jan; 62(1):121-130. PubMed ID: 29126489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of oral cancer. A multidisciplinary approach.
    Ord RA; Blanchaert RH
    J Am Dent Assoc; 2001 Nov; 132 Suppl():19S-23S. PubMed ID: 11803648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary Treatment of Locally Advanced Oral Cancer.
    Kim D; Li R
    Curr Treat Options Oncol; 2019 Mar; 20(4):32. PubMed ID: 30874958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.